Zenas BioPharma announces new obexelimab data.
- Phase 3 INDIGO open-label extension showed 93% flare-free rate at 12 months.
- Obexelimab reduced glucocorticoid toxicity by 11.4 points vs. placebo at week 52.
ZBIO
Zenas BioPharma, Inc. SEC filings
Every EDGAR filing for Zenas BioPharma, Inc. (ZBIO), newest first, with AI summaries and stories.
- Ticker
- ZBIO
- CIK
- 1953926
- Sector
- Biotech and pharma
- Latest filing
- 6d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE ROUTINES-3ASRZenas BioPharma, Inc.ZBIOLIVE ROUTINES-8Zenas BioPharma, Inc.ZBIOLIVE ROUTINESCHEDULE 13GZenas BioPharma, Inc.ZBIOLIVE 2 13G filings
Ownership stake disclosure by WELLINGTON MANAGEMENT GROUP LLP
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
WELLINGTON MANAGEMENT GROUP LLP, filed by
ROUTINE3Zenas BioPharma, Inc.ZBIOLIVE InnoCare Pharma Inc., new insider at ZBIO
InnoCare Pharma Inc., reporting
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE 2 insider filings
Christy J. Oliger, insider filing for ZBIO
Show all 2
- 4Insider filing for ZBIO
- 3New insider at ZBIO
Christy J. Oliger, reporting
NOTABLESCHEDULE 13D/AZenas BioPharma, Inc.ZBIOLIVE Ownership stake disclosure by Enavate Sciences GP, LLC (amended)
Enavate Sciences GP, LLC, filed by
ROUTINE144Zenas BioPharma, Inc.ZBIOLIVE Zebra Aggregator, LP, planned sale of ZBIO shares
Zebra Aggregator, LP, reporting
NOTABLESCHEDULE 13D/AZenas BioPharma, Inc.ZBIOLIVE Ownership stake disclosure by SR ONE CAPITAL MANAGEMENT, LLC (amended)
SR ONE CAPITAL MANAGEMENT, LLC, filed by
NOTABLE10-QZenas BioPharma, Inc.ZBIOLIVE ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE 10 insider filings
Jason Raleigh Nunn, insider filing for ZBIO
Show all 10
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
Jason Raleigh Nunn, reporting
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Leon O Moulder Jr, insider filing for ZBIO
Leon O Moulder Jr, reporting
NOTABLE10-QZenas BioPharma, Inc.ZBIOLIVE ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE NOTABLESCHEDULE 13DZenas BioPharma, Inc.ZBIOLIVE Ownership stake disclosure by Leon O Moulder Jr
Leon O Moulder Jr, filed by
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Leon O Moulder Jr, insider filing for ZBIO
Leon O Moulder Jr, reporting
NOTABLESCHEDULE 13D/AZenas BioPharma, Inc.ZBIOLIVE Ownership stake disclosure by Leon O Moulder Jr (amended)
Leon O Moulder Jr, filed by
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Hongbo Lu, insider filing for ZBIO
Hongbo Lu, reporting
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Peter Evan Harwin, insider filing for ZBIO
Peter Evan Harwin, reporting · Fairmount Healthcare Fund II L.P., reporting · +2 more
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Leon O Moulder Jr, insider filing for ZBIO
Leon O Moulder Jr, reporting
ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE Hongbo Lu, insider filing for ZBIO
Hongbo Lu, reporting
ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE ROUTINE424B5Zenas BioPharma, Inc.ZBIOLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
ROUTINEFWPZenas BioPharma, Inc.ZBIOLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- FWPSecurities offering
- FWPSecurities offering
ROUTINE424B5Zenas BioPharma, Inc.ZBIOLIVE 3 structured-note prospectuses
Securities offering
Show all 3
- 424B5Securities offering
- 424B5Securities offering
- FWPSecurities offering
ROUTINEDEFA14AZenas BioPharma, Inc.ZBIOLIVE ROUTINEARSZenas BioPharma, Inc.ZBIOLIVE ROUTINEDEF 14AZenas BioPharma, Inc.ZBIOLIVE ROUTINES-8Zenas BioPharma, Inc.ZBIOLIVE NOTABLE10-KZenas BioPharma, Inc.ZBIOLIVE ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE ROUTINE4Zenas BioPharma, Inc.ZBIOLIVE 2 insider filings
Hongbo Lu, insider filing for ZBIO
Show all 2
- 4Insider filing for ZBIO
- 4Insider filing for ZBIO
Hongbo Lu, reporting
ROUTINE8-KZenas BioPharma, Inc.ZBIOLIVE